Aman Mann 4/6/23 Aman Mann 4/6/23

AivoCode receives a $2.5M SBIR grant to develop a novel neurotherapeutic peptide for TBI

Aman Mann 4/6/23 Aman Mann 4/6/23

We are honored to announce AivoCode’s Scientific Founder and Chairman, Erkki Ruoslahti has been named a Lasker Laureate.

Aman Mann 5/17/22 Aman Mann 5/17/22

AivoCode presents at RESI March 2022

Kristin English 9/9/21 Kristin English 9/9/21

Awarded NIH Grant to Develop Therapies for Alzheimer’s Disease

AivoCode awarded a NIH grant to develop a novel therapeutic for Traumatic Brain Injury

Kristin English 9/1/19 Kristin English 9/1/19

AivoCode Awarded NIH Grant to Develop a Novel Therapeutic for Traumatic Brain Injury

AivoCode awarded a NIH grant to develop a novel therapeutic for Traumatic Brain Injury

Kristin English 11/10/17 Kristin English 11/10/17

Discovery May Show Earliest Stage of Alzheimer’s

A new way to detect Alzheimer’s disease at the earliest stages has been reported in a study led by researchers at the Sanford Burnham Prebys Medical Discovery Institute.

Kristin English 4/1/17 Kristin English 4/1/17

National Science Foundation Grant Awarded to AivoCode

National Science Foundation Small Business Innovation Research Phase II Grant: A Novel Platform to Enable Directed Delivery of Therapeutics into Brain Injuries awarded to AivoCode

Kristin English 12/20/16 Kristin English 12/20/16

Drug Couriers for Brain Injuries

A short protein fragment, or peptide, may lead the way to healing traumatic brain injuries, a primary cause of death and disability among youth.